Patent · US Active

Modified relaxin polypeptides comprising a non-naturally encoded amino acid in the A chain

US10702588B2 · kind B2 · utility

8Cited by
189References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 30, 2018
Grant dateJul 7, 2020
Priority date—
Expiry dateAug 1, 2038

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Modified relaxin polypeptides and their uses thereof are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.